In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children.
Children
DNA methylation
Metabolomics
Molecular phenotypes
Omics
Pregnancy
Secondhand smoke
Tobacco smoking
Transcription
miRNA
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
19 08 2020
19 08 2020
Historique:
received:
07
02
2020
accepted:
29
06
2020
entrez:
20
8
2020
pubmed:
20
8
2020
medline:
9
2
2021
Statut:
epublish
Résumé
The adverse health effects of early life exposure to tobacco smoking have been widely reported. In spite of this, the underlying molecular mechanisms of in utero and postnatal exposure to tobacco smoke are only partially understood. Here, we aimed to identify multi-layer molecular signatures associated with exposure to tobacco smoke in these two exposure windows. We investigated the associations of maternal smoking during pregnancy and childhood secondhand smoke (SHS) exposure with molecular features measured in 1203 European children (mean age 8.1 years) from the Human Early Life Exposome (HELIX) project. Molecular features, covering 4 layers, included blood DNA methylation and gene and miRNA transcription, plasma proteins, and sera and urinary metabolites. Maternal smoking during pregnancy was associated with DNA methylation changes at 18 loci in child blood. DNA methylation at 5 of these loci was related to expression of the nearby genes. However, the expression of these genes themselves was only weakly associated with maternal smoking. Conversely, childhood SHS was not associated with blood DNA methylation or transcription patterns, but with reduced levels of several serum metabolites and with increased plasma PAI1 (plasminogen activator inhibitor-1), a protein that inhibits fibrinolysis. Some of the in utero and childhood smoking-related molecular marks showed dose-response trends, with stronger effects with higher dose or longer duration of the exposure. In this first study covering multi-layer molecular features, pregnancy and childhood exposure to tobacco smoke were associated with distinct molecular phenotypes in children. The persistent and dose-dependent changes in the methylome make CpGs good candidates to develop biomarkers of past exposure. Moreover, compared to methylation, the weak association of maternal smoking in pregnancy with gene expression suggests different reversal rates and a methylation-based memory to past exposures. Finally, certain metabolites and protein markers evidenced potential early biological effects of postnatal SHS, such as fibrinolysis.
Sections du résumé
BACKGROUND
The adverse health effects of early life exposure to tobacco smoking have been widely reported. In spite of this, the underlying molecular mechanisms of in utero and postnatal exposure to tobacco smoke are only partially understood. Here, we aimed to identify multi-layer molecular signatures associated with exposure to tobacco smoke in these two exposure windows.
METHODS
We investigated the associations of maternal smoking during pregnancy and childhood secondhand smoke (SHS) exposure with molecular features measured in 1203 European children (mean age 8.1 years) from the Human Early Life Exposome (HELIX) project. Molecular features, covering 4 layers, included blood DNA methylation and gene and miRNA transcription, plasma proteins, and sera and urinary metabolites.
RESULTS
Maternal smoking during pregnancy was associated with DNA methylation changes at 18 loci in child blood. DNA methylation at 5 of these loci was related to expression of the nearby genes. However, the expression of these genes themselves was only weakly associated with maternal smoking. Conversely, childhood SHS was not associated with blood DNA methylation or transcription patterns, but with reduced levels of several serum metabolites and with increased plasma PAI1 (plasminogen activator inhibitor-1), a protein that inhibits fibrinolysis. Some of the in utero and childhood smoking-related molecular marks showed dose-response trends, with stronger effects with higher dose or longer duration of the exposure.
CONCLUSION
In this first study covering multi-layer molecular features, pregnancy and childhood exposure to tobacco smoke were associated with distinct molecular phenotypes in children. The persistent and dose-dependent changes in the methylome make CpGs good candidates to develop biomarkers of past exposure. Moreover, compared to methylation, the weak association of maternal smoking in pregnancy with gene expression suggests different reversal rates and a methylation-based memory to past exposures. Finally, certain metabolites and protein markers evidenced potential early biological effects of postnatal SHS, such as fibrinolysis.
Identifiants
pubmed: 32811491
doi: 10.1186/s12916-020-01686-8
pii: 10.1186/s12916-020-01686-8
pmc: PMC7437049
doi:
Substances chimiques
Biomarkers
0
Tobacco Smoke Pollution
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
243Subventions
Organisme : European Community's Seventh Framework Programme (FP7/2007-206)
ID : 308333
Pays : International
Organisme : Wellcome Trust
ID : WT101597MA
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024397/1
Pays : United Kingdom
Références
Diabetologia. 2015 Aug;58(8):1855-67
pubmed: 26049400
Blood. 2014 Nov 13;124(20):3155-64
pubmed: 25208887
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Am J Med Sci. 2001 Jul;322(1):19-23
pubmed: 11465242
J Adolesc Health. 2015 Feb;56(2):167-73
pubmed: 25529618
Epigenomics. 2019 Oct;11(13):1487-1500
pubmed: 31536415
Environ Health Perspect. 2017 Apr;125(4):760-766
pubmed: 27323799
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Circ Cardiovasc Genet. 2017 Oct;10(5):
pubmed: 29030400
BMC Genomics. 2017 May 26;18(1):413
pubmed: 28549425
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
RNA. 2010 Dec;16(12):2293-303
pubmed: 20980676
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Environ Health Perspect. 2012 Oct;120(10):1425-31
pubmed: 22851337
Nat Methods. 2014 Aug;11(8):809-15
pubmed: 24973947
Clin Epigenetics. 2019 Jul 1;11(1):97
pubmed: 31262328
Cardiovasc Ther. 2010 Oct;28(5):e72-91
pubmed: 20626406
PLoS One. 2012;7(7):e41361
pubmed: 22848472
J Nutr. 2020 Mar 1;150(3):568-578
pubmed: 31665391
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
BMC Bioinformatics. 2017 Jan 17;18(1):36
pubmed: 28095799
Hum Genet. 2012 May;131(5):747-56
pubmed: 22143225
BMC Bioinformatics. 2015 Apr 28;16:131
pubmed: 25928765
Clin Epigenetics. 2018 Oct 20;10(1):126
pubmed: 30342560
BMC Bioinformatics. 2016 Jun 29;17:259
pubmed: 27358049
Int J Environ Res Public Health. 2013 Nov 29;10(12):6485-99
pubmed: 24351784
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Lancet. 2011 Jan 8;377(9760):139-46
pubmed: 21112082
Physiol Rev. 2014 Oct;94(4):1027-76
pubmed: 25287859
J Cardiol. 2010 Nov;56(3):307-13
pubmed: 20943346
Epigenetics. 2018;13(2):129-134
pubmed: 28494218
Anal Chem. 2017 Jan 3;89(1):656-665
pubmed: 27959516
BMC Med. 2018 Nov 8;16(1):202
pubmed: 30404627
Genome Biol. 2015 Feb 15;16:37
pubmed: 25853392
BMJ Open. 2018 Sep 10;8(9):e021311
pubmed: 30206078
Int J Environ Res Public Health. 2009 Mar;6(3):1282-97
pubmed: 19440446
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Adv Clin Chem. 2014;67:1-45
pubmed: 25735858
Nicotine Tob Res. 2017 Apr 1;19(4):442-451
pubmed: 27613907
Environ Health Perspect. 2013 Feb;121(2):170-80
pubmed: 23232494
BMC Med. 2013 Mar 04;11:60
pubmed: 23497222
Anal Bioanal Chem. 2010 Jan;396(1):379-99
pubmed: 19466395
Hum Mol Genet. 2015 Apr 15;24(8):2201-17
pubmed: 25552657
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
Int J Epidemiol. 2017 Oct 1;46(5):1392-1393k
pubmed: 29040580
Bioinformatics. 2011 Jun 1;27(11):1496-505
pubmed: 21471010
Environ Health Perspect. 2015 Feb;123(2):193-9
pubmed: 25325234
Hum Mol Genet. 2016 Nov 1;25(21):4611-4623
pubmed: 28158590
Bioinformatics. 2019 Dec 15;35(24):5344-5345
pubmed: 31243429
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
Bioinformatics. 2014 Jul 15;30(14):2084-5
pubmed: 24659105
Mol Syst Biol. 2016 Mar 24;12(3):861
pubmed: 27013061
Int J Epidemiol. 2013 Aug;42(4):978-91
pubmed: 23064411
Int J Epidemiol. 2016 Oct;45(5):1644-1655
pubmed: 27591263
Anal Chem. 2009 Jan 1;81(1):56-66
pubmed: 19049366
BMC Bioinformatics. 2014 Sep 19;15:312
pubmed: 25239148
Am J Hum Genet. 2016 Apr 7;98(4):680-96
pubmed: 27040690
Mediators Inflamm. 2010;2010:513948
pubmed: 20508843
Cancer Inform. 2014 Jan 16;13:13-20
pubmed: 24526832
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Int J Epidemiol. 2012 Aug;41(4):930-40
pubmed: 21471022
BMC Pregnancy Childbirth. 2014 Jun 25;14:213
pubmed: 24964728
BMJ Open. 2013 Jan 24;3(1):
pubmed: 23355667
Trends Immunol. 2015 Nov;36(11):684-696
pubmed: 26497259
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636